Diclofenac sensitizes multi-drug resistant Acinetobacter baumannii to colistin.
Acinetobacter baumannii causes life-threatening infections that are becoming difficult to treat due to increasing rates of multi-drug resistance (MDR) among clinical isolates. This has led the World Health Organization and the CDC to categorize MDR A. baumannii as a top priority for the research and...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-11-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1012705&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850264581529665536 |
|---|---|
| author | Fabiana Bisaro Clay D Jackson-Litteken Jenna C McGuffey Anna J Hooppaw Sophie Bodrog Leila Jebeli Manon Janet-Maitre Juan C Ortiz-Marquez Tim van Opijnen Nichollas E Scott Gisela Di Venanzio Mario F Feldman |
| author_facet | Fabiana Bisaro Clay D Jackson-Litteken Jenna C McGuffey Anna J Hooppaw Sophie Bodrog Leila Jebeli Manon Janet-Maitre Juan C Ortiz-Marquez Tim van Opijnen Nichollas E Scott Gisela Di Venanzio Mario F Feldman |
| author_sort | Fabiana Bisaro |
| collection | DOAJ |
| description | Acinetobacter baumannii causes life-threatening infections that are becoming difficult to treat due to increasing rates of multi-drug resistance (MDR) among clinical isolates. This has led the World Health Organization and the CDC to categorize MDR A. baumannii as a top priority for the research and development of new antibiotics. Colistin is the last-resort antibiotic to treat carbapenem-resistant A. baumannii. Not surprisingly, reintroduction of colistin has resulted in the emergence of colistin-resistant strains. Diclofenac is a non-steroidal anti-inflammatory drug used to treat pain and inflammation associated with arthritis. In this work, we show that diclofenac sensitizes colistin-resistant A. baumannii clinical strains to colistin in vitro and in a murine model of pneumonia. Diclofenac also reduced the colistin minimal inhibitory concentration (MIC) of Klebsiella pneumoniae and Pseudomonas aeruginosa isolates. Transcriptomic and proteomic analyses revealed an upregulation of oxidative stress-related genes and downregulation of type IV pili induced by the combination treatment. Notably, the concentrations of colistin and diclofenac effective in the murine model were substantially lower than those determined in vitro, implying a stronger synergistic effect in vivo compared to in vitro. A pilA mutant strain, lacking the primary component of the type IV pili, became sensitive to colistin in the absence of diclofenac. This suggest that the downregulation of type IV pili is key for the synergistic activity of these drugs in vivo and indicates that colistin and diclofenac exert an anti-virulence effect. Together, these results suggest that diclofenac can be repurposed with colistin to treat MDR A. baumannii. |
| format | Article |
| id | doaj-art-1ad9a855fd774d0c971b10a9506d6913 |
| institution | OA Journals |
| issn | 1553-7366 1553-7374 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj-art-1ad9a855fd774d0c971b10a9506d69132025-08-20T01:54:40ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742024-11-012011e101270510.1371/journal.ppat.1012705Diclofenac sensitizes multi-drug resistant Acinetobacter baumannii to colistin.Fabiana BisaroClay D Jackson-LittekenJenna C McGuffeyAnna J HooppawSophie BodrogLeila JebeliManon Janet-MaitreJuan C Ortiz-MarquezTim van OpijnenNichollas E ScottGisela Di VenanzioMario F FeldmanAcinetobacter baumannii causes life-threatening infections that are becoming difficult to treat due to increasing rates of multi-drug resistance (MDR) among clinical isolates. This has led the World Health Organization and the CDC to categorize MDR A. baumannii as a top priority for the research and development of new antibiotics. Colistin is the last-resort antibiotic to treat carbapenem-resistant A. baumannii. Not surprisingly, reintroduction of colistin has resulted in the emergence of colistin-resistant strains. Diclofenac is a non-steroidal anti-inflammatory drug used to treat pain and inflammation associated with arthritis. In this work, we show that diclofenac sensitizes colistin-resistant A. baumannii clinical strains to colistin in vitro and in a murine model of pneumonia. Diclofenac also reduced the colistin minimal inhibitory concentration (MIC) of Klebsiella pneumoniae and Pseudomonas aeruginosa isolates. Transcriptomic and proteomic analyses revealed an upregulation of oxidative stress-related genes and downregulation of type IV pili induced by the combination treatment. Notably, the concentrations of colistin and diclofenac effective in the murine model were substantially lower than those determined in vitro, implying a stronger synergistic effect in vivo compared to in vitro. A pilA mutant strain, lacking the primary component of the type IV pili, became sensitive to colistin in the absence of diclofenac. This suggest that the downregulation of type IV pili is key for the synergistic activity of these drugs in vivo and indicates that colistin and diclofenac exert an anti-virulence effect. Together, these results suggest that diclofenac can be repurposed with colistin to treat MDR A. baumannii.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1012705&type=printable |
| spellingShingle | Fabiana Bisaro Clay D Jackson-Litteken Jenna C McGuffey Anna J Hooppaw Sophie Bodrog Leila Jebeli Manon Janet-Maitre Juan C Ortiz-Marquez Tim van Opijnen Nichollas E Scott Gisela Di Venanzio Mario F Feldman Diclofenac sensitizes multi-drug resistant Acinetobacter baumannii to colistin. PLoS Pathogens |
| title | Diclofenac sensitizes multi-drug resistant Acinetobacter baumannii to colistin. |
| title_full | Diclofenac sensitizes multi-drug resistant Acinetobacter baumannii to colistin. |
| title_fullStr | Diclofenac sensitizes multi-drug resistant Acinetobacter baumannii to colistin. |
| title_full_unstemmed | Diclofenac sensitizes multi-drug resistant Acinetobacter baumannii to colistin. |
| title_short | Diclofenac sensitizes multi-drug resistant Acinetobacter baumannii to colistin. |
| title_sort | diclofenac sensitizes multi drug resistant acinetobacter baumannii to colistin |
| url | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1012705&type=printable |
| work_keys_str_mv | AT fabianabisaro diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT claydjacksonlitteken diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT jennacmcguffey diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT annajhooppaw diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT sophiebodrog diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT leilajebeli diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT manonjanetmaitre diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT juancortizmarquez diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT timvanopijnen diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT nichollasescott diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT giseladivenanzio diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin AT marioffeldman diclofenacsensitizesmultidrugresistantacinetobacterbaumanniitocolistin |